Daclatasvir Dihydrochloride and Medroxyprogesterone Injection (400 mg/mL)
Determining the interaction of Daclatasvir Dihydrochloride and Medroxyprogesterone Injection (400 mg/mL) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: Medroxyprogesterone, MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Medroxyprogesterone Injection (Intramuscular)
- Daclatasvir Dihydrochloride-Medroxyprogesterone Injection (Subcutaneous)
- Daclatasvir Dihydrochloride-Medroxyprogesterone Injection ER
- Daclatasvir Dihydrochloride-Medroxyprogesterone Intramuscular
- Daclatasvir Dihydrochloride-Medroxyprogesterone Tablets
- Daclatasvir Dihydrochloride-Medworx Patch
- Medroxyprogesterone Injection (400 mg/mL)-Daclizumab
- Medroxyprogesterone Injection (400 mg/mL)-Daclizumab Subcutaneous
- Medroxyprogesterone Injection (400 mg/mL)-Dacogen
- Medroxyprogesterone Injection (400 mg/mL)-Dacomitinib
- Medroxyprogesterone Injection (400 mg/mL)-Dactinomycin
- Medroxyprogesterone Injection (400 mg/mL)-Dactinomycin Injection